Phenylbutyrate Treatment in a Boy With MCT8 Deficiency: Improvement of Thyroid Function Tests and Possible Hepatotoxicity
The Journal of Clinical Endocrinology & Metabolism · 2025
DOI: 10.1210/clinem/dgae356 ↗Kurz gefasst
Fallbericht in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2025. Verfasst von Felix Schreiner und 8 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric Endocrinology Division, Children's Hospital, University Hospital Bonn, 53127 Bonn, Germany. Hauptthemen laut MEDLINE: Monocarboxylic Acid Transporters, Muscle Hypotonia, Phenylbutyrates, X-Linked Intellectual Disability. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 25 Literaturangaben. Gefördert von: Sherman Foundation, Deutsche Forschungsgemeinschaft.
Abstract (Originalsprache)
Context
Monocarboxylate transporter 8 (MCT8) deficiency is a rare X-chromosomal inherited disease leading to severe cognitive impairment, muscular hypotonia, and symptoms of peripheral thyrotoxicosis. Experimental approaches aiming to functionally rescue mutant MCT8 activity by the chemical chaperone phenylbutyrate (PB) demonstrated promising effects in vitro for several MCT8 missense mutations.
Objective
The objective was to evaluate biochemical and clinical effects of PB in doses equivalent to those approved for the treatment of urea cycle disorders in a boy with MCT8 deficiency due to a novel MCT8 missense mutation c.703G>T (p.V235L).
Results
During a treatment period of 13 months, PB led to a significant decrease of elevated thyrotropin and triiodothyronine (T3) serum concentrations, while free thyroxine (fT4) increased. The weight z-score of the toddler remained remarkably stable during the treatment period. Neurodevelopmental assessments (BSID-III) revealed a slight increase of gross motor skills from developmental age 4 to 6 months. However, increasing liver enzyme serum activities and accumulation of phenylacetate in urine led to treatment interruptions and dose alterations. In vitro analyses in MDCK1 cells confirmed the pathogenicity of MCT8 p.V235L. However, while PB increased expression of the mutant protein, it did not rescue T3 transport, suggesting a PB effect on thyroid function tests independent of restoring MCT8 activity.
Conclusion
In a clinical attempt of PB treatment in MCT8 deficiency we observed a significant improvement of thyroid hormone function tests, tendencies toward body weight stabilization and slight neurodevelopmental improvement. Hepatotoxicity of PB may be a limiting factor in MCT8 deficiency and requires further investigation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pediatric Endocrinology Division, Children's Hospital, University Hospital Bonn, 53127 Bonn, Germany.
- Institute of Biochemistry and Molecular Biology, University Hospital Bonn, University of Bonn, 53115 Bonn, Germany.
- Department of Pediatric Neurology, Children's Hospital, University Hospital Bonn, 53127 Bonn, Germany.
- Pediatric Endocrinology Division, Children's Hospital, University Hospital Erlangen, 91054 Erlangen, Germany.
ORCID-Profile: Felix Schreiner
Förderung
- Sherman Foundation
- Deutsche Forschungsgemeinschaft
Zitieren
APA
Schreiner, F., Vollbach, H., Sonntag, N., Schempp, V., Gohlke, B., Friese, J., Woelfle, J., Braun, D., & Schweizer, U. (2025). Phenylbutyrate Treatment in a Boy With MCT8 Deficiency: Improvement of Thyroid Function Tests and Possible Hepatotoxicity. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgae356
Vancouver
Schreiner F, Vollbach H, Sonntag N, Schempp V, Gohlke B, Friese J, et al. Phenylbutyrate Treatment in a Boy With MCT8 Deficiency: Improvement of Thyroid Function Tests and Possible Hepatotoxicity. The Journal of Clinical Endocrinology & Metabolism. 2025. doi:10.1210/clinem/dgae356
BibTeX
@article{Schreiner2025,
author = {Schreiner, Felix and Vollbach, Heike and Sonntag, Niklas and Schempp, Vera and Gohlke, Bettina and Friese, Johannes and Woelfle, Joachim and Braun, Doreen and Schweizer, Ulrich},
title = {Phenylbutyrate Treatment in a Boy With MCT8 Deficiency: Improvement of Thyroid Function Tests and Possible Hepatotoxicity},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2025},
doi = {10.1210/clinem/dgae356}
}
EUVIMED